News

Article October 15, 2018

New Immunotherapy Targeting Blood-Clotting Protein Protects Multiple Sclerosis and Alzheimer’s Disease Models

Gladstone researchers have stopped the detrimental effects of blood-brain barrier leaks

News Release Research (Publication) Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab

Article November 2, 2017

Blood-Clotting Protein Prevents Repair in the Brain

Study may lead to new treatments for diseases like multiple sclerosis

Akassoglou Lab Multiple Sclerosis

Article January 26, 2017

Gladstone Investigator Receives $5.8M Grant for Pioneering Research into Neurological Disease

The NINDS award provides longer-term support and increased flexibility to pursue innovative, high-risk research on neurological diseases.

Multiple Sclerosis Akassoglou Lab

Article October 12, 2016

A New Way to Think about Neurological Diseases

Katerina Akassoglou is calling for a fundamental change in the way scientists approach neurological disorders. Her research on the brain’s vascular and immune systems has led to new insights about multiple sclerosis and other conditions.

Multiple Sclerosis Akassoglou Lab

Article September 7, 2016

Gladstone Investigator Receives $5.8M Career Grant

The NINDS award provides longer-term support and increased flexibility to pursue innovative, high-risk research on neurological diseases.

Neurological Disease Akassoglou Lab

Article January 11, 2016

Brain Receptor Regulates Fat Burning in Cells

Scientists at the Gladstone Institutes have discovered an unusual regulator of body weight and the metabolic syndrome: a molecular mechanism more commonly associated with brain cells.

Diabetes Neurological Disease Akassoglou Lab Basic Science Metabolism

Article October 9, 2015

Blood Clotting Protein Triggers Immune Attack on the Brain

A new study from the Gladstone Institutes shows that a single drop of blood in the brain is sufficient to activate an autoimmune response akin to multiple sclerosis (MS).

Akassoglou Lab Multiple Sclerosis

Article September 10, 2015

Profile: Victoria Rafalski, PhD

Victoria Rafalski, a postdoctoral scholar in the Akassoglou lab, encourages young scientists to pursue a career that aligns with their personal values.

Akassoglou Lab

Article January 29, 2015

Gladstone Investigator Receives Award for Innovation in Multiple Sclerosis Research

Katerina Akassoglou is working to identify a biomarker that could track the progression of multiple sclerosis using blood tests

Akassoglou Lab Multiple Sclerosis

December 4, 2013

Molecular Sensor Detects Early Signs of Multiple Sclerosis, Gladstone Study Finds

SAN FRANCISCO, CA—For some, the disease multiple sclerosis (MS) attacks its victims slowly and progressively over a period of many years. For others, it strikes without warning in fits and starts.

Akassoglou Lab Neurological Disease Multiple Sclerosis

June 17, 2013

Key Protein is Linked to Circadian Clocks; Helps Regulate Metabolism

SAN FRANCISCO, CA—Inside each of us is our own internal timing device. It drives everything from sleep cycles to metabolism, but the inner-workings of this so-called “circadian clock” are complex, and the molecular processes behind it have long eluded scientists.

Akassoglou Lab Metabolism

November 26, 2012

Gladstone Scientists Identify Key Biological Mechanism in Multiple Sclerosis

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis (MS)—a disease that causes progressive and irreversible damage to nerve cells in the brain and spinal cord.

Akassoglou Lab Multiple Sclerosis

March 27, 2012

Gladstone Scientists Identify Key Mechanism Involved in Type 2 Diabetes

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have discovered a key protein that regulates insulin resistance—the diminished ability of cells to respond to the action of insulin and which sets the stage for the development of the most common form of diabetes.

Akassoglou Lab Diabetes Metabolism

July 20, 2010

Gladstone and Lundbeck Collaborate to Study Neurovascular Disease and Identify Novel Therapeutic Strategies

SAN FRANCISCO, CA—The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases.

Akassoglou Lab Multiple Sclerosis